↓ Skip to main content

Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States

Overview of attention for article published in Frontiers in Pharmacology, August 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
8 X users
facebook
2 Facebook pages

Readers on

mendeley
95 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States
Published in
Frontiers in Pharmacology, August 2016
DOI 10.3389/fphar.2016.00285
Pubmed ID
Authors

Brian F. Thomas, Gerald T. Pollard

Abstract

Cannabis is classified as a schedule I controlled substance by the US Drug Enforcement Agency, meaning that it has no medicinal value. Production is legally restricted to a single supplier at the University of Mississippi, and distribution to researchers is tightly controlled. However, a majority of the population is estimated to believe that cannabis has legitimate medical or recreational value, numerous states have legalized or decriminalized possession to some degree, and the federal government does not strictly enforce its law and is considering rescheduling. The explosive increase in open sale and use of herbal cannabis and its products has occurred with widely variable and in many cases grossly inadequate quality control at all levels-growing, processing, storage, distribution, and use. This paper discusses elements of the analytical and regulatory system that need to be put in place to ensure standardization for the researcher and to reduce the hazards of contamination, overdosing, and underdosing for the end-user.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Unknown 93 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 16%
Student > Bachelor 13 14%
Student > Master 10 11%
Student > Ph. D. Student 9 9%
Student > Doctoral Student 7 7%
Other 19 20%
Unknown 22 23%
Readers by discipline Count As %
Medicine and Dentistry 10 11%
Pharmacology, Toxicology and Pharmaceutical Science 10 11%
Agricultural and Biological Sciences 8 8%
Chemistry 7 7%
Engineering 7 7%
Other 25 26%
Unknown 28 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2018.
All research outputs
#6,514,038
of 25,257,066 outputs
Outputs from Frontiers in Pharmacology
#2,844
of 19,472 outputs
Outputs of similar age
#94,382
of 346,193 outputs
Outputs of similar age from Frontiers in Pharmacology
#34
of 155 outputs
Altmetric has tracked 25,257,066 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 19,472 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,193 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 155 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.